Angiolab, Inc. (XKON:251280)
South Korea
· Delayed Price · Currency is KRW
4,000.00
-90.00 (-2.20%)
At close: Aug 14, 2025, 3:30 PM KST
Angiolab Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2015 | FY 2014 |
| Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
| Net Income | -1,187 | -350.31 |
| Depreciation & Amortization | 232.44 | 152.02 |
| Asset Writedown & Restructuring Costs | 526.96 | - |
| Provision & Write-off of Bad Debts | - | 16.3 |
| Other Operating Activities | 48.69 | 43.09 |
| Change in Accounts Receivable | -2.57 | -38.95 |
| Change in Inventory | 54.85 | -49.79 |
| Change in Accounts Payable | 16.01 | - |
| Change in Other Net Operating Assets | 227.4 | 45.25 |
| Operating Cash Flow | -82.73 | -182.39 |
| Capital Expenditures | -22.57 | - |
| Sale (Purchase) of Intangibles | -70.04 | -42.01 |
| Investment in Securities | 1,089 | -2,823 |
| Other Investing Activities | 233.92 | -323.42 |
| Investing Cash Flow | 1,231 | -3,189 |
| Long-Term Debt Issued | - | 100 |
| Long-Term Debt Repaid | -600 | - |
| Net Debt Issued (Repaid) | -600 | 100 |
| Issuance of Common Stock | - | 2,993 |
| Financing Cash Flow | -600 | 3,093 |
| Miscellaneous Cash Flow Adjustments | - | 0 |
| Net Cash Flow | 547.94 | -277.86 |
| Free Cash Flow | -105.3 | -182.39 |
| Free Cash Flow Margin | -14.99% | -20.76% |
| Free Cash Flow Per Share | -120.34 | -208.26 |
| Levered Free Cash Flow | -44.36 | - |
| Unlevered Free Cash Flow | -43.78 | - |
| Change in Working Capital | 295.69 | -43.48 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.